Phase 3 Pancreatic Ductal Adenocarcinoma trials recruiting now
All Pancreatic Ductal Adenocarcinoma trials, every phase
7
Phase 3 recruiting
Other phases for Pancreatic Ductal Adenocarcinoma
Phase 3 Pancreatic Ductal Adenocarcinoma trials
- A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer
- Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types
- Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer
- Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
- Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
- Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas
Common questions
What does Phase 3 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.